Answer:
Hydrolysis reactions use water to breakdown polymers into monomers and is the opposite of dehydration synthesis, which forms water when synthesizing a polymer from monomers. Hydrolysis reactions break bonds and release energy.
Answer:
Answer is A. Cdk7 of the CAK (TFIIH component) phosphorylates Cyclin 8 of the Mediator to down regulate promoter activity.
Refer below.
Explanation:
Cdk7 of the CAK (TFIIH component) phosphorylates Cyclin 8 of the Mediator to down regulate promoter activity is a FALSE STATEMENT.
Answer:
<em><u>It is a C4 plant 100% sur</u></em>e
hope i helped
-lvr
Answer:
the fundamental unit of heredity
Explanation:
DNA is a double stranded helix structure. Each strand is made up of a string of nucleotides.
A gene is a region of DNA, usually tens of thousands of nucleotides long. At the simplest level, one gene encodes for one trait. Therefore, the gene can be described as the fundamental unit of heredity.
Genes work by coding for specific proteins, which carry out essentially all the functions in the cell.
Answer:
Thermosensitive liposomes (TSL) are promising tools used to deliver drugs to targeted region when local hyperthermia is applied (∼40–42°C) which triggers the membrane phase transformation from a solid gel-like state to a highly permeable liquid state. Selective lipid components have been used to in TSL formulations to increase plasma stability before hyperthermia and speed drug release rate after. Two generations of TSL technology have been developed. The traditional thermal sensitive liposomes (TTSL) have utilized DPPC and DSPC as a combination. The second generation, lysolipid thermally sensitive liposomes (LTSL) technology, has been developed with incorporation of lysolipids that form stabilized defects at phase transition temperature. LTSL maintains certain favorable attributes:
High percentage of lysolipids incorporation;
Minimum leakage for therapeutical drugs encapsulation;
Ultrafast drug release upon heating (3.5 times enhanced compared to TTSL). For example, ThermoDox, a commonly used LTSL drug for cancer, has been reported to release 100% of the encapsulated doxorubicin within 30s;
First and most successful formulation for intravascular drug release.
Explanation:
https://www.creative-biostructure.com/Lysolipid-Thermally-Sensitive-Liposomes-Production-612.htm
